Skip to main content
. 2020 Dec 3;27(2):236–245. doi: 10.3350/cmh.2020.0204

Figure 2.

Figure 2.

Grade of response to cTACE in BCLC stage B HCC. Reprinted from Bruix et al. [45] with permission from S. Karger AG. RFA, radiofrequency ablation; cTACE, conventional transarterial chemoembolization; DEB-TACE, drug-eluting beads transarterial chemoembolization; IO, immune-oncology; TKI, tyrosine kinase inhibitor; BCLC, Barcelona Clinic Liver Cancer; HCC, hepatocellular carcinoma.